SIBO Research

What Does the Research Say About SIBO and SIBO Breath Testing?

A curated selection of research to help practitioners and patients understand the evidence behind SIBO and SIBO breath testing.

Small Intestinal Bacterial Overgrowth (SIBO) and SIBO breath testing are widely studied in the scientific literature. Like many areas of medicine, there is ongoing discussion around testing methods, interpretation and clinical application.

This page provides information and research to give a balanced, evidence-based perspective.

Section 01

Is SIBO a Real Condition?

SIBO is a recognised medical condition, characterised by an abnormal increase in bacterial levels in the small intestine.

The World Health Organization (WHO) recognises SIBO in its International Classification of Diseases and Related Health Problems (ICD) – ICD-11. The ICD is the global standard for disease classification, used as the basis for health recording, statistics, research and health service planning worldwide.

While awareness of SIBO has grown significantly in recent years, it is not a new concept. SIBO has been described in the medical literature for decades and continues to be actively researched, particularly in relation to functional gastrointestinal disorders such as Irritable Bowel Syndrome (IBS).

Some scepticism still exists; however, a substantial body of research validates SIBO, its clinical relevance and the role of breath testing in assessing this condition within a clinical context.

Research
  • Modern Concepts of Small Intestinal Bacterial Overgrowth Barlow & Pimentel, 2025 Up-to-date review covering evolving concepts, mechanisms, small intestinal sampling, breath testing and definitions of SIBO. View study →
  • Mechanisms and Pathophysiology Leading to the Development of Small Intestinal Microbial Dysbiosis Damianos et al., 2026 Reviews the biological pathways through which bacterial overgrowth establishes itself in the small intestine. View study →
  • The Duodenal Microbiome is Altered in Small Intestinal Bacterial Overgrowth Leite et al., 2020 Demonstrates altered duodenal microbiome composition in people with SIBO compared with non-SIBO controls. View study →
  • A Meta-Analysis on Small Intestinal Bacterial Overgrowth in Patients with Different Subtypes of Irritable Bowel Syndrome Ghoshal et al., 2020 Meta-analysis showing IBS patients were significantly more likely to have SIBO than healthy controls, with IBS-D showing the highest rates of hydrogen-positive breath tests and IBS-C showing the highest methane. View study →
Section 02

How is SIBO Tested?

There are two primary methods used to assess SIBO:

Duodenal Aspirate

Direct sampling of fluid from the proximal small intestine is traditionally considered the ‘gold standard’. However, like most tests, this method has limitations:

  • Invasive and costly
  • Limited accessibility
  • Risk of contamination
  • May miss overgrowth in other areas of the small intestine

While still a valuable procedure in certain clinical situations, research suggests a lactulose breath test may be preferable to an aspirate, as it is safer, cheaper and less likely to yield a contaminated result.

Breath Testing

Breath testing is a non-invasive, widely used clinical tool that measures hydrogen and methane gases produced by microbes.

SIBO breath testing is:

  • Accessible and cost-effective
  • Suitable for at-home or in-clinic use
  • Able to provide useful insight into gas patterns over time

International guidelines, including the North American Consensus, provide standardised protocols for preparation and interpretation of breath tests in clinical practice.

To find out more about SIBO breath testing, visit here →

Research
  • Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus Rezaie et al., 2017 Foundational guideline establishing standardised protocols for breath test preparation, administration and interpretation. View study →
  • Diagnosing SIBO: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates Cangemi et al., 2020 Concludes that a lactulose breath test may be preferable to an aspirate, as it is safer, cheaper and less likely to yield a contaminated result. View study →
  • Detection Capacity of Small Intestine Bacterial or Methanogen Overgrowth by Lactose and Fructose Breath Testing in the Adult Population Laserna Mendieta et al., 2024 Examines the ability of lactose and fructose breath tests to detect small intestinal bacterial or methanogen overgrowth in adults, supporting the emerging use of fructose as a substrate not only for malabsorption testing but also for SIBO detection. View study →
  • A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects IMO Takakura et al., 2022 Demonstrates fasting methane level ≥10 ppm had a sensitivity of 86.4% and specificity of 100% for diagnosing IMO and directly correlated with stool Methanobrevibacter smithii load. View study →
Section 03

Understanding Breath Testing and Its Limitations

Breath testing has been widely studied and is influenced by several physiological and methodological factors. As with many clinical tools, results can vary depending on how the test is performed, reported and interpreted.

Factors that influence breath test results include:

Patient’s gastrointestinal transit time
Patient adherence to preparation and pre-test guidelines
Substrate used and dose administered
Sampling intervals and test duration
Type of collection system used
Reference range and interpretation guidelines used
Measurement of key gases, including hydrogen and methane
Individual patients’ gas production patterns and interactions

When these factors aren’t taken into consideration, results may vary or be inconsistent. For example:

Patient preparation

Not following the pre-test diet or guidelines may result in elevated baseline gases, which can impact the interpretation of subsequent readings.

Substrate dose

At high doses, lactulose may act as a laxative, increasing transit time and the likelihood of false positives. Similarly, excessive fructose dosing can exceed normal absorptive capacity, even in healthy individuals.

Type of substrate

Lactulose is a non-absorbable carbohydrate and can assess fermentation along the length of the gastrointestinal tract, whereas glucose is absorbed proximally and may miss more distal fermentation.

Sample intervals

Longer sample intervals may fail to capture possible rises in gas production, especially in the case of glucose.

This is why standardised, research-based guidelines matter.

Importantly, variations in study design (such as different preparation, substrate dose or interpretation criteria) contribute to differences in reported accuracy across the literature. This is a key reason why SIBO breath testing is sometimes viewed inconsistently.

No test is perfect. SIBO breath testing is a useful clinical tool when used correctly alongside clinical assessment, symptom presentation and informed practitioner judgement.

When performed in line with established guidelines, the limitations of SIBO breath testing can be reduced, and its clinical utility significantly improved.

Research
  • Pros and Cons of Breath Testing for SIBO and IMO Rezaie et al., 2023 Balanced clinical review of breath testing strengths and limitations, providing a practical framework for appropriate use. View study →
  • Understanding Our Tests: Hydrogen-Methane Breath Testing to Diagnose Small Intestinal Bacterial Overgrowth Tansel & Levinthal, 2023 Comprehensive review of hydrogen-methane breath testing, including indications, administration, patient factors and test performance characteristics across clinical scenarios. View study →
  • Glucose Breath Test for the Detection of Small Intestine Bacterial Overgrowth: Impact of Diet Prior to the Test Mattio et al., 2024 Demonstrates how a strict preparation diet before a breath test can decrease baseline levels and improve the diagnostic quality of the test. View study →
Section 04

Interpretation & Clinical Relevance

Breath Test Interpretation

Interpreting a breath test involves more than a simple positive or negative result. Considerations include:

Baseline readings
Gas patterns over time
Hydrogen and methane relationships
Carbon dioxide as a quality control marker
The substrate used and how or when it is absorbed
Patient-specific context, including symptoms, medical history and test preparation

Accurate interpretation, combined with appropriate test protocols, plays a key role in reducing limitations and improving the usefulness of breath testing in practice.

Watch Dr. Nirala Jacobi walk through breath test interpretation →

Clinical Relevance

Beyond the result, SIBO breath testing provides clinically useful information that can support treatment decisions. It helps practitioners to:

  • Identify and/or differentiate between SIBO and Intestinal Methanogen Overgrowth (IMO)
  • See the relationship between measured gases
  • Inform more targeted and individualised treatment approaches
  • Identify potential drivers of symptoms such as bloating, constipation or diarrhoea
  • Monitor changes over time and response to treatment

In clinical practice, this information helps guide decision-making and supports a more structured, personalised approach to patient care.

When used appropriately, SIBO breath testing offers insights into the small intestinal environment that are difficult to obtain through other methods.

Research
  • Extended Hydrogen Breath Test Analysis for Optimised Diagnosis of SIBO-Positive IBS Patients Dahlgren et al., 2026 Follow-up from Dahlgren et al., 2025 confirms that lactulose hydrogen breath testing detects genuine small intestinal fermentation, and validating ≥20 ppm within 80 minutes as the optimal diagnostic threshold. View study →
  • AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review Quigley et al., 2020 American Gastroenterological Association expert review affirming the clinical role of breath testing and outlining best-practice approaches to SIBO assessment and management. View study →
  • Methanogens, Methane and Gastrointestinal Motility Triantafyllou et al., 2014 Establishes the physiological basis for why methane-dominant breath test patterns are clinically distinct, showing methane directly slows intestinal transit, linking IMO to constipation-predominant symptoms. View study →
  • Symptomatic Response to Antibiotics in Patients With Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-analysis Takakura et al., 2024 IBS patients with a positive SIBO breath test were more than twice as likely to respond to antibiotics than those without, directly demonstrating that breath testing guides treatment decisions. View study →
Section 05

Associated Conditions

SIBO has been studied in association with a range of gastrointestinal and systemic conditions. Each condition below links to supporting research. These associations do not imply causation, but highlight the potential role of the small intestine and gut microbiota in broader health and disease.

These conditions include, but are not limited to:

To learn more, visit The SIBO Doctor.